<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2016</study_start_year><condition>COLORECTAL METASTATIC CANCER</condition><condition>CARCINOMA COLON-RETTO METASTATICO</condition><condition>Metastatic colorectal cancer</condition><disease>Metastatic Colorectal Cancer</disease><disease>Carcinoma Colon-retto Metastatico</disease><disease>Colorectal Metastatic Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2535482</full_dataset_link><location>Italy</location><study_start_month>7</study_start_month><keyword>proleukin</keyword><keyword>ENDOXAN</keyword><repository>ECRIN MDR</repository><study_status>Ongoing</study_status></additional><is_claimable>false</is_claimable><name>RESTORE IMMUNE COMPETENCE AGAINST CANCER CELLS IN METASTATIC COLON-RECTAL CARCINOMA RESISTANT TO STANDARD TREATMENTS
TRANSLATE – Colon-rectal STUDY</name><description>Primary objectives: Objective response rate</description><dates><creation>2016-07-15</creation></dates><accession>2535482</accession><cross_references><EU Clinical Trials Register>2016-000578-39</EU Clinical Trials Register></cross_references></HashMap>